Patent win to help co gain Europe mkt share : Poly Medicure

The European safety catheter market is seen at USD 250 million. Himnanshu Baid, MD of Poly Medicure, believes with these patent wins, and given a 2-3 year horizon, the company can gain 6-7 percent market share

Poly Medicure , manufacturers of medical devises, won a 5-year long patent battle versus German firm B Braun. The European Patent Office (EPO) revoked two of B Braun's patents and Himnanshu Baid, managing director of Poly Medicure, expects it to be a huge positive for the company.

He says the patent win will help the company gain a firm foothold in Europe. The patents are for intravenous safety catheters. The European safety catheter market is seen at USD 250 million. Baid believes with these patent wins, and given a 2-3 year horizon, the company can gain 6-7 percent market share.

Transcript to follow…

Poly Medicure stock price

On September 08, 2014, at 11:12 hrs Poly Medicure was quoting at Rs 802.05, up Rs 77.00, or 10.62 percent. The 52-week high of the share was Rs 810.00 and the 52-week low was Rs 221.50.

The company's trailing 12-month (TTM) EPS was at Rs 19.60 per share as per the quarter ended March 2014. The stock's price-to-earnings (P/E) ratio was 40.92. The latest book value of the company is Rs 53.07 per share. At current value, the price-to-book value of the company is 15.11.

Anda sedang membaca artikel tentang

Patent win to help co gain Europe mkt share : Poly Medicure

Dengan url

https://olahragakecantikan.blogspot.com/2014/09/patent-win-to-help-co-gain-europe-mkt.html

Olahraga Kecantikan